Patrick J. Crutcher

VP, Business Development, Avalo Therapeutics, Inc.

Companies

Jasper Therapeutics, Inc.Board member Jul 20, 2026 to now¹
Amanat Acquisition Corp.Board member May 19, 2026 to now²
Avalo Therapeutics, Inc.VP, Business Development Sep 27, 2018 to Apr 2, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jasper Therapeutics, Inc. JSPR518,331 shares⁴$246.7K at $0.48Jul 20, 2026

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJasper Therapeutics, Inc., Board member
2
SEC EDGARAmanat Acquisition Corp., Board member
3
SEC EDGARAvalo Therapeutics, Inc., VP, Business Development
4
SEC EDGARJasper Therapeutics, Inc. shares after the filing of Jul 20, 2026